These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28962779)

  • 1. Linear polymers of β and γ cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin.
    Oliveri V; Bellia F; Viale M; Maric I; Vecchio G
    Carbohydr Polym; 2017 Dec; 177():355-360. PubMed ID: 28962779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Charged Polymeric Cyclodextrins for Biomedical Applications.
    Bognanni N; Bellia F; Viale M; Bertola N; Vecchio G
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33808780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy.
    Bognanni N; Viale M; Distefano A; Tosto R; Bertola N; Loiacono F; Ponassi M; Spinelli D; Pappalardo G; Vecchio G
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.
    Viale M; Tosto R; Giglio V; Pappalardo G; Oliveri V; Maric I; Mariggiò MA; Vecchio G
    Invest New Drugs; 2019 Aug; 37(4):771-778. PubMed ID: 30556100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
    Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
    Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New doxorubicin nanocarriers based on cyclodextrins.
    Viale M; Giglio V; Monticone M; Maric I; Lentini G; Rocco M; Vecchio G
    Invest New Drugs; 2017 Oct; 35(5):539-544. PubMed ID: 28378257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An injectable drug-loaded hydrogel based on a supramolecular polymeric prodrug.
    Xiong L; Luo Q; Wang Y; Li X; Shen Z; Zhu W
    Chem Commun (Camb); 2015 Oct; 51(78):14644-7. PubMed ID: 26290273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes.
    Zhao MX; Zhao M; Zeng EZ; Li Y; Li JM; Cao Q; Tan CP; Ji LN; Mao ZW
    J Inorg Biochem; 2014 Aug; 137():31-9. PubMed ID: 24803024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin polymers as nanocarriers for sorafenib.
    Giglio V; Viale M; Bertone V; Maric I; Vaccarone R; Vecchio G
    Invest New Drugs; 2018 Jun; 36(3):370-379. PubMed ID: 29116478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure, and evaluation of a β-cyclodextrin-artificial carbohydrate conjugate for use as a doxorubicin-carrying molecule.
    Yamanoi T; Oda Y; Katsuraya K; Inazu T; Hattori K
    Bioorg Med Chem; 2016 Feb; 24(4):635-42. PubMed ID: 26746345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.
    Wang T; Zhang C; Liang XJ; Liang W; Wu Y
    J Pharm Sci; 2011 Mar; 100(3):1067-79. PubMed ID: 20922814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.
    Anand R; Malanga M; Manet I; Manoli F; Tuza K; Aykaç A; Ladavière C; Fenyvesi E; Vargas-Berenguel A; Gref R; Monti S
    Photochem Photobiol Sci; 2013 Oct; 12(10):1841-54. PubMed ID: 23900688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of bisacodyl with modified β-cyclodextrins: Characterization, molecular modeling, and effect of PEG.
    Li S; Wang L; Jiang J; Tang P; Wang Q; Wu D; Li H
    Carbohydr Polym; 2015 Dec; 134():82-91. PubMed ID: 26428103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexes of polyglutamic acid and long-chain alkanoylcholines: nanoparticle formation and drug release.
    Tolentino A; Alla A; Martínez de Ilarduya A; Muñoz-Guerra S
    Int J Biol Macromol; 2014 May; 66():346-53. PubMed ID: 24582932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
    J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin.
    Zhang D; Zhang J; Jiang K; Li K; Cong Y; Pu S; Jin Y; Lin J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():501-8. PubMed ID: 26254603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosponge formulations as oxygen delivery systems.
    Cavalli R; Akhter AK; Bisazza A; Giustetto P; Trotta F; Vavia P
    Int J Pharm; 2010 Dec; 402(1-2):254-7. PubMed ID: 20888402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier.
    Gil ES; Wu L; Xu L; Lowe TL
    Biomacromolecules; 2012 Nov; 13(11):3533-41. PubMed ID: 23066958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and ITC characterization of novel nanoparticles constituted by poly(gamma-benzyl L-glutamate)-beta-cyclodextrin.
    Barbosa ME; Bouteiller L; Cammas-Marion S; Montembault V; Fontaine L; Ponchel G
    J Mol Recognit; 2008; 21(3):169-78. PubMed ID: 18438968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.